ARCHIVES

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 32 | September 4, 2009

Download PDF Visit The Full Archive

Related Articles

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002